4.4 Article

Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours

Journal

BRITISH JOURNAL OF RADIOLOGY
Volume 88, Issue 1045, Pages -

Publisher

BRITISH INST RADIOLOGY
DOI: 10.1259/bjr.20140412

Keywords

-

Funding

  1. Federal Ministry of Education and Research, Germany (BMBF) [03ZIK042]

Ask authors/readers for more resources

Objective: To investigate radiochemotherapy (RChT)-induced changes of transfer coefficient (K-trans) and relative tumour blood volume (rTBV) estimated by dynamic contrast-enhanced CT (DCE-CT) and fractal analysis in head and neck tumours (HNTs). Methods: DCE-CT was performed in 15 patients with inoperable HNTs before RChT, and after 2 and 5 weeks. The dynamics of K-trans and rTBV as well as lacunarity, slope of log(lacunarity) vs log(box size), and fractal dimension were compared with tumour behaviour during RChT and in the 24-month follow-up. Results: In 11 patients, an increase of K-trans and/or rTBV after 20Gy followed by a decrease of both parameters after 50Gy was noted. Except for one local recurrence, no tumour residue was found during the follow-up. In three patients with partial tumour reduction during RChT, a decrease of K-trans accompanied by an increase in rTBV between 20 and 50Gy was detected. In one patient with continuous elevation of both parameters, tumour progressed after RChT. Pre-treatment difference in intratumoral heterogeneity with its decline under RChT for the responders vs non-responders was observed. Conclusion: Initial growth of K-trans and/or rTBV followed by further reduction of both parameters along with the decline of the slope of log(lacunarity) vs log(box size) was associated with positive radiochemotherapeutic response. Increase of K-trans and/or rTBV under RChT indicated a poor outcome. Advances in knowledge: The modification of K-trans and rTBV as measured by DCE-CT may be applied for the assessment of tumour sensitivity to chose RChT regimen and, consequently, to reveal clinical impact allowing individualization of RChT strategy in patients with HNT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available